Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3723812012 | Mogamulizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3723813019 | Product containing mogamulizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1142511000172118 | produit contenant du mogamulizumab sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1156171000172116 | product dat mogamulizumab in parenterale vorm bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mogamulizumab-containing product in parenteral dose form | Is a | Product containing mogamulizumab (medicinal product) | true | Inferred relationship | Some | ||
| Mogamulizumab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Mogamulizumab-containing product in parenteral dose form | Has active ingredient | Mogamulizumab (substance) | true | Inferred relationship | Some | 1 | |
| Mogamulizumab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Mogamulizumab-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only mogamulizumab in parenteral dose form (medicinal product form) | Is a | True | Mogamulizumab-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
FHIR